Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Rabbit anti-human cardiac Troponin I (cTnI) monoclonal antibody (clone 5D11)
AP36772MD11
500 Items
Overview
DESCRIPTION | |
Species Reactivity | Human cTnI |
Immunogen | Full length native human cTnI protein |
Purity | > 95% via protein A purification |
Formulation | 0.22 µM filtered solution of PBS, pH 7.4 |
Size | 50µl (concentration 1mg/mL) |
APPLICATION | |
ELISA | 1) capture antibody: rabbit anticTnI monoclonal antibody (clone 5D11, AP36772MD11) at 1 µg/ml 2) detection antibody: rabbit anti-cTnI monoclonal antibody (clone 5A16, AP36772MA16) at 0.5 µg/ml |
Pairing Antibody | AP36772ML9 AP36772MA16 |
Turbidimetric Immunoassay | Tested |
Research Use or Further Manufacturing Only. | |
PREPARATION AND STORAGE | |
Preparation | Monoclonal antibody is produced by immunizing rabbit with full length human cTnI and purified using protein A resin. |
Storage | This antibody is shipped at 4 oC. This product is stable for 12 months from date of receipt when stored at -20oC to -70oC. Avoid freeze/thaw cycles |
BACKGROUND
Cardiac troponin I, cTnI, is exclusively expressed in cardiac muscle tissue in a single isoform with molecular weight ~24 KD. cTnI forms complex with cardiac Troponin T (cTnT) and Troponin C (TnC) to regulate the formation of actomyosin filament and subsequent cardiac muscle contraction. During cardiac muscle tissue injury, cTnI is released into the blood of patient and indicative of cardiac cell death. cTnI has been widely used as a sensitive and specific diagnostic marker of acute myocardial infarction (AMI), post-surgery myocardium trauma, chemotherapy cardiotoxicity, and some other diseases linked to cardiac muscle injury. In recent years, high-sensitivity cTnI assay has been used to accurately diagnose AMI after the onset of acute chest pain. |